SCL Science Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
63
- Stock Symbol
-
246960
- Investments
-
7
- Share Price
-
$1.49
- (As of Friday Closing)
SCL Science General Information
Description
SCL Science Inc formerly InnoTherapy Inc is a South-Korea based medical device company. It has developed a technology to control physical property of bio-inspired by the adhesive properties of living organisms. The products offered by the company include InnoSEAL, EndoSil and GellySil among others.
Contact Information
Website
www.sclscience.comCorporate Office
- Unit 1211, Ace High-Tech City 2
- 25, Seonyu-ro 13-gil
- Seoul, Yeongdeungpo 07282
- South Korea
Corporate Office
- Unit 1211, Ace High-Tech City 2
- 25, Seonyu-ro 13-gil
- Seoul, Yeongdeungpo 07282
- South Korea
SCL Science Timeline
SCL Science Stock Performance
As of 13-Nov-2026, SCL Science’s stock price is $1.49. Its current market cap is $50.7M with 34M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.49 | $1.46 | $0.95 - $2.19 | $50.7M | 34M | 148K | $0.02 |
SCL Science Financials Summary
As of 30-Jun-2026, SCL Science has a trailing 12-month revenue of $21M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 52,647 | 29,299 | 41,337 | 51,028 |
| Revenue | 21,017 | 15,466 | 3,472 | 1,011 |
| EBITDA | 1,507 | 83 | (1,808) | (2,779) |
| Net Income | (2,332) | (2,765) | (2,734) | (3,844) |
| Total Assets | 51,135 | 55,503 | 16,333 | 23,402 |
| Total Debt | 19,090 | 19,971 | 2,891 | 5,939 |
SCL Science Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
SCL Science Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SCL Science Patents
SCL Science Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025127408-A1 | Hydrogel comprising hyaluronic acid derivative polymer | Inactive | 14-Dec-2023 | ||
| WO-2025095562-A1 | Hydrogel comprising hyaluronic acid derivative polymer | Inactive | 31-Oct-2023 | ||
| WO-2024101889-A1 | Wound dressing derived from fish skin | Inactive | 11-Nov-2022 | ||
| EP-4218840-A1 | Biocompatible film and method for producing same | Inactive | 26-Oct-2020 | ||
| EP-4218840-A4 | Biocompatible film and method for producing same | Inactive | 26-Oct-2020 | A61L27/20 |
SCL Science Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SCL Science Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
SCL Science Investments & Acquisitions (7)
SCL Science’s most recent deal was a Merger/Acquisition with Avison Care. The deal was made on 03-Feb-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Avison Care | 03-Feb-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Seoul Medical Science Research Institute (Regional Bio-Logistics Business Operations) | 31-Dec-2025 | Merger/Acquisition | Logistics | ||
| Neogenlogic | 17-Oct-2025 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Pentamedix | 11-Sep-2025 | Merger/Acquisition | Drug Discovery | ||
| H2U Health | 08-Feb-2024 | Later Stage VC | Application Software |
SCL Science ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
SCL Science Exits (1)
SCL Science’s most recent exit was on 08-Feb-2024 from H2U Health. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| H2U Health | 08-Feb-2024 | Completed |
|
SCL Science Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Neogenlogic | Seongnam, South Korea | 2019 |
SCL Science FAQs
-
When was SCL Science founded?
SCL Science was founded in 2010.
-
Where is SCL Science headquartered?
SCL Science is headquartered in Seoul, South Korea.
-
What is the size of SCL Science?
SCL Science has 63 total employees.
-
What industry is SCL Science in?
SCL Science’s primary industry is Discovery Tools (Healthcare).
-
Is SCL Science a private or public company?
SCL Science is a Public company.
-
What is SCL Science’s stock symbol?
The ticker symbol for SCL Science is 246960.
-
What is the current stock price of SCL Science?
As of 13-Nov-2026 the stock price of SCL Science is $1.49.
-
What is the current market cap of SCL Science?
The current market capitalization of SCL Science is $50.7M.
-
What is SCL Science’s current revenue?
The trailing twelve month revenue for SCL Science is $21M.
-
What is SCL Science’s annual earnings per share (EPS)?
SCL Science’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
